And on day 35, the tumor volume in the groups treated with PBS reached 3,503 mm3, with luteolin 3,080 mm3, and with VV‐IL‐24 1,088 mm3, while in the combination group of VV‐IL‐24 with luteolin tumor volume was 105 mm3, documenting significant inhibition of the tumor growth (Figure 4A). This evidence concerns the gene IL24 and neoplasm.